Co-Diagnostics Inc (NASDAQ:CODX) traded at $0.36 at close of the session on Tuesday, May 13 and made an upward move of 6.06% on its previous day’s price.
Co-Diagnostics Inc has a market cap of $12.22 million and is expected to release its quarterly earnings report in June.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 300k, with a low of 300k and a high of 300k. The median projection represents growth adding up to -88.71% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 950k, or -75.74% down from figures reported last year.
On the other hand, looking at the outlook for the CODX stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is 2.17% off its SMA20 and -7.88% from its 50-day simple moving average. The RSI (14) is pointing at 48.71 while the volatility over the past week is 17.24% and jumps to 11.33% over the past one month. The beta value is 0.68, while the average true range (ATR) is currently pointing at 0.05. The average price target for the stock over the next 12 months is $6, with the estimates having a low of $6 and a high of $6. These price ends are -1566.67% and -1566.67% off the current price level respectively, although investors could be excited at the prospect of a -1566.67% if the CODX share price touches on the median price of $6.
